Whether it’s for a clinical trial in the pharmaceutical, biotechnology or medical device industry, WCC’s highly trained, full-service global CRO team is dedicated to solving the most complex study designs with end-to-end imaging services and unparalleled radiology expertise. Leveraging its in-house trial experts and strategic relationships with world-class radiology groups, WCC provides customized solutions that meet your project needs. From clinical operations and regulatory affairs specialists to biostatistics and data management experts, WCC offers an unprecedented wealth of resources to ensure an efficient and successful trial process and outcome.
History
Orginally begun in 1992 as part of the Massachusetts General Hospital (MGH) Department of Radiology, WCC was established as an independent company in 1995. As a valuable addition to our in-house team, we today maintain a strategic relationship with the MGH Department of Radiology, which allows us to provide our sponsors with unparalleled access to world-class radiological expertise.
WCC also draws extensive global technology expertise and teleradiology capabilities from our parent company ProScan Imaging, which acquired majority ownership of WCC in 2006. As one of the world's most trusted and experienced radiology providers, ProScan enables us to manage virtually any volume of images for our trials, while evolving our service offerings and expanding our global reach as the imaging industry grows.
WorldCare Clinical is an imaging CRO that employs imaging expertise, innovative technology and operational excellence to maximize the precision and accuracy of a blinded independent central review (BICR) of clinical trial data.
WorldCare Clinical (WCC) has assembled a world-class leadership team that guides our pursuit of excellence in clinical trial imaging.
Members of WCC's executive management team include:
Richard Walovitch, Ph.D., President. Dr. Walovitch is president of WCC, which he joined as chief medical officer in January 2009. Prior to joining WCC, he served as the senior vice president of clinical research at Acusphere, Inc., vice president of preclinical and clinical research at Epix Medical, and held various positions as research pharmacologist and project clinician in the Imaging Agent Group at the DuPont Merck Pharmaceutical Company. He completed his postdoctoral fellowship at the National Institute on Drug Abuse’s Addiction Research Center in the Neurochemistry section. Walovitch has a doctorate in pharmacology from the University of Illinois Medical Center and a bachelor’s degree in biology from the University of Illinois. He is an author of more than 100 peer-reviewed publications, mostly in the field of medical imaging.
Kevin Jarry, CPA, Senior Controller. Mr. Jarry is the senior controller of WCC, where he directs the company’s financial policy while also being an active participant in, and driver of, the organization’s overall strategy. He leads all financial administration, business planning and budgeting. He has more than 12 years of experience in financial management including more than 10 years in the industry. Prior to his current position, he managed the accounting department for Ascent Technology. In addition, he has previously worked on several consulting projects assisting companies with financial operations and tax preparation. He is a Certified Public Accountant and received a B.S. degree in accounting from Bryant University, and M.B.A. and M.S. of taxation degrees from Bentley University’s McCallum Graduate School of Business.
John Tomera, Ph.D., Director of Regulatory Affairs & Associate Medical Director. Dr. Tomera is director of regulatory affairs and associate medical director of WCC. Prior to joining WCC, he served as director of regulatory affairs at Biopure Corporation in Cambridge, as clinical development director of oncology agents at Point Therapeutic, and as manager of statistical quality assurance within biostatistics/biometrics at Biogen Idec. He has diverse experience across a variety of clinical therapeutic areas and contributed to five drug/biologic approvals, none of which have been recalled, prior to joining WCC. Tomera holds a doctorate in pharmacology from Temple University School of Medicine, and a B.S. from the University of Pittsburgh. He has also held postdoctoral posts at the Harvard School of Public Health and at the Massachusetts Institute of Technology (MIT). Subsequently, he held a faculty position as an assistant professor of anesthesiology (pharmacology) at Harvard Medical School, with appointments in the Anesthesia Services at the Massachusetts General Hospital and Shriners Burns Institute in Boston. He is author of 60 published articles over a variety of world-class journals.
Helen Le, Director of Clinical Operations. As director of clinical operations at WCC, Ms. Le is responsible for developing and monitoring standardized workflow processes and working with regulatory and quality assurance (QA) to develop standard operating procedures for the operations team. Ms. Le started working as a clinical research associate in 2003 and has held multiple positions of increased responsibility in clinical operations. Prior to joining WCC in 2003 Le worked as a medical assistant and as a patient-family relations liaison at Brigham and Women’s Hospital in Boston. She has also worked as an HIV/AIDS prevention educator for the Boys and Girls Club of Brockton. Le received a bachelor’s degree in biology from Boston University.
Patrick Chokron, Director of Software Engineering. Mr. Chokron is director of software engineering for WCC, where he is responsible for architecting and developing information systems for managing phase II and phases III clinical trial studies and for ensuring the integrity of electronic clinical data submitted for regulatory purposes. In addition to his position at WCC, Chokron acts as a consultant to various organizations needing information system analysis, design or development. Prior to joining WCC in 2003 as clinical systems software engineer and manager, Chokron served as lead software engineer for EnrichNet Inc. and project coordinator at Infosilem Inc. He has also worked as a programmer building management applications for network hardware components for NHC Communications Inc. Chokron earned his B.S. in computer science from McGill University in Montreal, Quebec.
Richard Taranto, Executive Vice President, Business Development. Mr. Taranto is executive vice president of business development at WCC. Since joining WCC in 2002, he has managed multiple clinical imaging trials for biopharmaceutical and medical device companies, including more than 25 Phase II-IV studies, and developed and implemented management tools to streamline organizational effectiveness. Before coming to WCC, Mr. Taranto was senior project manager at Perceptive Informatics. He earned a B.S. degree in zoology from the University of Rhode Island and an M.B.A. from Boston College.
We offer an innovative and challenging environment for creative thinkers with excellent problem-solving skills and the ability to thrive in a dynamic atmosphere. In addition to fostering internal growth and advancement for its employees, WCC offers a comprehensive benefits program that includes:
Current Job Openings:
Even if there are currently no specific opportunities relevant to your experience open, we encourage interested candidates to submit a resume. We will notify qualified applicants in the event an appropriate position becomes available.
To apply, please submit your cover letter and resume to: careers@wcclinical.com
Fax: +1-513-352-9436
WorldCare Clinical – A 20 Year Heritage in Imaging Expertise
WorldCare Clinical, LLC (WCC) was originally founded in 1992 by the Massachusetts General Hospital (MGH) Department of Radiology. While maintaining a strategic relationship with MGH, WCC has evolved as an independent company into a leading global imaging CRO that employs imaging expertise, innovative technology and operational excellence to maximize the precision and accuracy of a blinded independent central review of clinical trial data. With a 20-year focus on imaging trials and their specific requirements, WCC provides sponsors with extensive medical, operational and image management expertise in support of even the most complex study designs.
© 2012 WorldCare Clinical
